These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 34866362)
1. Computational detection of a genome instability-derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma. Guo CR; Mao Y; Jiang F; Juan CX; Zhou GP; Li N Cancer Med; 2022 Feb; 11(3):864-879. PubMed ID: 34866362 [TBL] [Abstract][Full Text] [Related]
2. Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer. Bao S; Zhao H; Yuan J; Fan D; Zhang Z; Su J; Zhou M Brief Bioinform; 2020 Sep; 21(5):1742-1755. PubMed ID: 31665214 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma. Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618 [TBL] [Abstract][Full Text] [Related]
4. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma. Tang X; Miao Y; Wang J; Cai T; Yang L; Mi D Comput Math Methods Med; 2021; 2021():1205029. PubMed ID: 34840594 [TBL] [Abstract][Full Text] [Related]
5. Genome instability-related LINC02577, LINC01133 and AC107464.2 are lncRNA prognostic markers correlated with immune microenvironment in pancreatic adenocarcinoma. Zhang Y; Wang Y; He X; Yao R; Fan L; Zhao L; Lu B; Pang Z BMC Cancer; 2023 May; 23(1):430. PubMed ID: 37173624 [TBL] [Abstract][Full Text] [Related]
6. Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer. Chen S; Li X; Zhang J; Li L; Wang X; Zhu Y; Guo L; Wang J J Gastrointest Oncol; 2021 Oct; 12(5):2157-2171. PubMed ID: 34790382 [TBL] [Abstract][Full Text] [Related]
7. A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability. Cui T; Guo J; Sun Z Expert Rev Mol Diagn; 2022 Feb; 22(2):213-222. PubMed ID: 34871123 [TBL] [Abstract][Full Text] [Related]
8. Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature. Wu H; Zhang ZY; Zhang Z; Xiao XY; Gao SL; Lu C; Zuo L; Zhang LF Bioengineered; 2021 Dec; 12(1):1725-1738. PubMed ID: 33955803 [TBL] [Abstract][Full Text] [Related]
9. Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma. Geng W; Lv Z; Fan J; Xu J; Mao K; Yin Z; Qing W; Jin Y Front Cell Dev Biol; 2021; 9():657667. PubMed ID: 33855028 [No Abstract] [Full Text] [Related]
10. Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma. Yang L; Guo G; Yu X; Wen Y; Lin Y; Zhang R; Zhao D; Huang Z; Wang G; Yan Y; Zhang X; Chen D; Xing W; Wang W; Zeng W; Zhang L Front Oncol; 2022; 12():780631. PubMed ID: 35372012 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Genomic Instability of m Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906 [No Abstract] [Full Text] [Related]
12. Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma. Mai S; Liang L; Mai G; Liu X; Diao D; Cai R; Liu L Front Endocrinol (Lausanne); 2022; 13():829175. PubMed ID: 35422758 [TBL] [Abstract][Full Text] [Related]
13. Development of six immune-related lncRNA signature prognostic model for smoking-positive lung adenocarcinoma. Zhou D; Wang J; Liu X J Clin Lab Anal; 2022 Jun; 36(6):e24467. PubMed ID: 35561270 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma. Peng B; Li H; Na R; Lu T; Li Y; Zhao J; Zhang H; Zhang L Front Cell Dev Biol; 2021; 9():706454. PubMed ID: 34336859 [TBL] [Abstract][Full Text] [Related]
15. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung. Miao H; Chen D; Li R; Hu J; Chen Y; Xu C; Wen Z Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324975 [TBL] [Abstract][Full Text] [Related]
16. Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma. Huang DP; Liao MM; Tong JJ; Yuan WQ; Peng DT; Lai JP; Zeng YH; Qiu YJ; Tong GD Aging (Albany NY); 2021 Nov; 13(22):24621-24639. PubMed ID: 34799469 [TBL] [Abstract][Full Text] [Related]
17. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma. Chen M; Liu B; Xiao J; Yang Y; Zhang Y Oncotarget; 2017 Feb; 8(9):14876-14886. PubMed ID: 28122330 [TBL] [Abstract][Full Text] [Related]
18. Genome instability-related long non-coding RNA in clear renal cell carcinoma determined using computational biology. Wang Y; Yan K; Wang L; Bi J BMC Cancer; 2021 Jun; 21(1):727. PubMed ID: 34167490 [TBL] [Abstract][Full Text] [Related]
19. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma. Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492 [TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma. Ren J; Wang A; Liu J; Yuan Q Bioengineered; 2021 Dec; 12(1):4331-4348. PubMed ID: 34338158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]